Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test.
In August CTS begins source plasma testing as a new line of business to one of the largest plasma fr...
Transitioned all 6 CTS labs from an investigational new drug (IND) to a licensed Zika test, and anno...
In October, due to demand from existing healthcare partners, CTS began testing blood donors for anti...
In August, the CTS Tampa lab transitioned to the same laboratory information systems (LIS) as the Da...
In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million).
As a component of the CTS Business Continuity Plan, today all 6 labs began using the same laboratory...